相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity
Yi-Wen Shen et al.
TRENDS IN CANCER (2021)
Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies
Rong Fu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery
Zihao Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells
Oriol de Barrios et al.
GUT (2019)
A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours
Rong Fu et al.
NATURE COMMUNICATIONS (2019)
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
Eugene Tulchinsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
Massimiliano Cadamuro et al.
JOURNAL OF HEPATOLOGY (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer
Irene Sangrador et al.
CANCER RESEARCH (2018)
The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma
Javier Vaquero et al.
CLINICAL CANCER RESEARCH (2018)
Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
Jente van Staalduinen et al.
ONCOGENE (2018)
The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
Alessandra Gentilini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
Javier A. Garcia-Vilas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
Javier Vaquero et al.
JOURNAL OF HEPATOLOGY (2017)
ZEB1-regulated inflammatory phenotype in breast cancer cells
Akihiro Katsura et al.
MOLECULAR ONCOLOGY (2017)
Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles
Marlies Cortes et al.
EMBO JOURNAL (2017)
ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma
Katsumi Terashita et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Waltraut Lehmann et al.
NATURE COMMUNICATIONS (2016)
Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ling-Jun Ho et al.
BIOCHEMICAL PHARMACOLOGY (2015)
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
Patricia Marti et al.
HEPATOLOGY (2015)
EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition
Audrey Claperon et al.
JOURNAL OF HEPATOLOGY (2014)
Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
Peter Bronsert et al.
SURGERY (2014)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma Through Activation of Epidermal Growth Factor Receptor
Audrey Claperon et al.
HEPATOLOGY (2013)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The role of the ZEB family of transcription factors in development and disease
C. Vandewalle et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
c-Met targeted therapy of cholangiocarcinoma
Matei P. Socoteanu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma
A Gardini et al.
DIGESTIVE AND LIVER DISEASE (2005)
Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin αvβ3 and heparan sulfate proteoglycan
RP Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis
AW Rachfal et al.
HEPATOLOGY RESEARCH (2003)
Effects and regulation of connective tissue growth factor on hepatic stellate cells
V Paradis et al.
LABORATORY INVESTIGATION (2002)
分享论文
